-
FDA Grants Expanded Indication for AMVUTTRA® (vutrisiran) in the U.S.
Now available to treat a new group of patients
Learn More ›
-
Alnylam Named a Most Responsible Company by Newsweek
We are honored to be recognized for the third year in a row
Learn More ›
-
Alnylam is recognized as a Top Place to Work for the 10th year in a row
We’re proud to consecutively top The Boston Globe’s Massachusetts Largest Employer list
Learn More ›
-
Alnylam Named a Top Science Employer by Science Magazine
This is our 6th consecutive year on the Science Magazine Top Employer list
Learn More ›
-
Alnylam Recognized as a Best Workplace for Innovators
2024 marks our fourth consecutive year on the Fast Company list
Learn More ›
-
Alnylam Named a Top 100 Company by Humankind
Investment firm list includes the U.S.’s most ethical companies.
Learn More ›
